Mazdutide

Mazdutide is presented here as a laboratory catalogue entry for research environments that need clear identification, labelled variants, and direct access to supporting records. The current listing includes 2 labelled variants: 5mg and 10mg. That structure keeps the page useful as both a procurement reference and an indexable resource covering stock visibility, pricing context, and documentation.

Within the wider Au Peptide Labs catalogue, Mazdutide sits alongside Retatrutide, Tesamorelin, and Ipamorelin. Researchers often review neighbouring compounds before selecting a comparator or deciding which sequence belongs in a screening panel. Keeping those internal paths close to the product page improves traceability and helps laboratory buyers compare materials without relying on vague or consumer-style copy.

In research literature, Mazdutide is generally treated as a GLP-1R/GcgR dual agonist (IBI362) designed with a C18 fatty acid modification for extended half-life in pharmacokinetic research models. Mazdutide activates the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GcgR) — both class B GPCRs — with differential potency ratios engineered to bias signalling toward GLP-1 pathway outputs while retaining GcgR-mediated increases in hepatic cAMP relevant to lipid oxidation assay models. This GLP-1-biased dual agonism is structurally distinct from tirzepatide (GIP/GLP-1) and retatrutide (GLP-1/GIP/GcgR), placing mazdutide in a unique position in head-to-head receptor-selectivity comparator panels.

The GLP-1/glucagon dual-agonist class is of particular interest in receptor pharmacology because glucagon and GLP-1 share ~50% sequence homology yet produce opposed metabolic responses in hepatocyte models. Peptides that activate both simultaneously allow dissection of whether GcgR agonism amplifies or competes with GLP-1R outputs at the cellular level. For laboratory teams, the practical emphasis is usually on sequence identity, receptor or pathway relevance where documented, and whether Mazdutide behaves consistently across stability, purity, and analytical verification workflows. Variant labels on this page support clearer internal referencing when multiple labelled variants are under review.

If a product-specific file is not attached to this listing, the wider COA library remains the correct reference point for current published documentation. The COA section is useful for confirming how the product is labelled in the catalogue, whether purity information has been published, and whether the laboratory record for the material is complete before bench use.

When teams compare Mazdutide with Retatrutide, Tesamorelin, and Ipamorelin, COA access also helps keep comparator decisions grounded in documented material identity rather than assumption. That is especially important for research pages that combine pricing, variant selection, and analytical records on a single URL.